Download PDF
Thromb Haemost 1990; 64(03): 490-491
DOI: 10.1055/s-0038-1647345
Letter to the Editor
Schattauer GmbH Stuttgart

Specific Anti-Xa Activity of LMWH (Kabi 2165, CY216 PK 10169) Against the First International Standard of LMWH: A Collaborative Study

M D Dautzenberg
*   Laboratoire Central d’Hématalogie Hôpital NECKER-Enfants Malades, Paris, France
,
L Bara
**   Laboratoire de Thrombose Expérimentale Faculté de Médecine, Paris, France
,
P Cornu
*   Laboratoire Central d’Hématalogie Hôpital NECKER-Enfants Malades, Paris, France
,
M Samama
**   Laboratoire de Thrombose Expérimentale Faculté de Médecine, Paris, France
› Author Affiliations
Further Information

Publication History

Received 27 April 1990

Accepted after revision 27 June 1990

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Barrowcliffe TW, Curtis AD, Johnson EA, Thomas DP. An International Standard for low molecular weight heparin. Thromb Haemostas 1988; 60: 1-7
    PubMedGoogle Scholar
  • 2 Barrowcliffe TW, Curtis AD, Tomlinson TP, Hubbard AR, Johnson EA, Thomas DP. Standardization of low molecular weight heparin: a collaborative study. Thromb Haemostas 1985; 54: 675-680
    PubMedGoogle Scholar
  • 3 Bara L, Samama MM. The need for standardization of low molecular weight heparin (LMWH). Thromb Haemostas 1986 56. 418 (Letter).
    PubMedGoogle Scholar
  • 4 Fareed J, Hoppensteadt D, Walenga JM, Huan X, Messmore HL. Validity of the newly established low molecular weight heparin. Standard in cross referencing low molecular weight heparins. Haemostasis 1988; 18 suppl (Suppl. 03) 33-47
    PubMedGoogle Scholar
  • 5 Hemker HC. A standard for low molecular weight heparin. Haemostasis 1989; 1: 1-4
    PubMedGoogle Scholar